| scholarly article | Q13442814 |
| P50 | author | Takeshi Yoshitomi | Q42702350 |
| P2093 | author name string | Makoto Ishikawa | |
| P2860 | cites work | The long-term safety and efficacy of brinzolamide 1.0% (azopt) in patients with primary open-angle glaucoma or ocular hypertension. The Brinzolamide Long-Term Therapy Study Group | Q28145191 |
| Neurons and networks in daily rhythms | Q28249827 | ||
| Beta-blocker eyedrops and nocturnal arterial hypotension | Q28373592 | ||
| A comparative study of the effects of brinzolamide and dorzolamide on retinal oxygen saturation and ocular microcirculation in patients with primary open-angle glaucoma | Q33325870 | ||
| The efficacy and safety of unfixed and fixed combinations of latanoprost and other antiglaucoma medications | Q34805085 | ||
| Systemic adverse effects of beta-adrenergic blockers: an evidence-based assessment | Q34995347 | ||
| Brinzolamide : a review of its use in the management of primary open-angle glaucoma and ocular hypertension | Q35562610 | ||
| Short term efficacy and safety in glaucoma patients changed to the latanoprost 0.005%/timolol maleate 0.5% fixed combination from monotherapies and adjunctive therapies | Q35592524 | ||
| Side effects associated with prostaglandin analog therapy | Q37336335 | ||
| Adverse reactions from timolol administration | Q42272642 | ||
| Comparing diurnal and nocturnal effects of brinzolamide and timolol on intraocular pressure in patients receiving latanoprost monotherapy | Q42609540 | ||
| Role of nocturnal arterial hypotension in optic nerve head ischemic disorders | Q42689687 | ||
| Additive intraocular pressure lowering effect of various medications with latanoprost | Q44010317 | ||
| Comparison of the nocturnal effects of once-daily timolol and latanoprost on intraocular pressure | Q44414154 | ||
| Rate of response to latanoprost or timolol in patients with ocular hypertension or glaucoma | Q44674915 | ||
| Topical prostaglandin F(2alpha) analog induced poliosis | Q44882982 | ||
| Concomitant administration of travoprost and brinzolamide versus fixed latanoprost/timolol combined therapy: three-month comparison of efficacy and safety. | Q45070851 | ||
| Intraocular pressure lowering effect of brinzolamide 1.0% as adjunctive therapy to latanoprost 0.005% in patients with open angle glaucoma or ocular hypertension: an uncontrolled, open-label study | Q46494993 | ||
| Comparison of ocular hypotensive effect and safety of brinzolamide and timolol added to latanoprost | Q46643376 | ||
| Increase of peak intraocular pressure during sleep in reproduced diurnal changes by posture | Q48513150 | ||
| Effects of timolol, epinephrine, and acetazolamide on aqueous flow during sleep | Q49034505 | ||
| Nocturnal blood pressure and intraocular pressure measurement in glaucoma patients and healthy controls. | Q50960820 | ||
| Prevention of dermatologic side effects of bimatoprost 0.03% topical therapy. | Q51095495 | ||
| The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. | Q53612490 | ||
| ??? | Q94347988 | ||
| Medical Management of Glaucoma | Q58541816 | ||
| Ocular Beta-Blockers and Systemic Effects | Q72591940 | ||
| Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes | Q72924060 | ||
| Effect of brinzolamide and dorzolamide on aqueous humor flow in human eyes | Q73052474 | ||
| Dose-response evaluation of the ocular hypotensive effect of brinzolamide ophthalmic suspension (Azopt). Brinzolamide Dose-Response Study Group | Q73425559 | ||
| Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension | Q74150874 | ||
| Comparison of 24-hour intraocular pressure reduction with two dosing regimens of latanoprost and timolol maleate in patients with primary open-angle glaucoma | Q78245024 | ||
| Carbonic Anhydrase Inhibition and Aqueous Flow | Q78614755 | ||
| Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost | Q79428904 | ||
| Effect of concomitant use of latanoprost and brinzolamide on 24-hour variation of IOP in normal-tension glaucoma | Q80482398 | ||
| Risk factors for incident open-angle glaucoma: the Barbados Eye Studies | Q80608143 | ||
| Brimonidine purite 0.1% versus brinzolamide 1% as adjunctive therapy to latanoprost in patients with glaucoma or ocular hypertension | Q94696745 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | circadian rhythm | Q208353 |
| latanoprost | Q634959 | ||
| open-angle glaucoma | Q3108586 | ||
| P304 | page(s) | 493-500 | |
| P577 | publication date | 2009-09-07 | |
| P1433 | published in | Clinical Ophthalmology | Q5133782 |
| P1476 | title | Effects of brinzolamide vs timolol as an adjunctive medication to latanoprost on circadian intraocular pressure control in primary open-angle glaucoma Japanese patients | |
| P478 | volume | 3 |
Search more.